- Corporate Officers - D
- Dekkers Marijn E
Insider Trading History of Dekkers Marijn E
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dekkers Marijn E since 2006.
This trader's CIK number is 1216068.
At the time of last reporting, Dekkers Marijn E was the Director of Ginkgo Bioworks Holdings, Inc.. (stock ticker symbol DNA).
Also see all insider trading activities at Ginkgo Bioworks Holdings, Inc..
Note that in the past
DEKKERS MARIJN E also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at General Electric Co (GE) by Dekkers Marijn E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | GE | 20,000 | $598,000 | 0 | $0 | 0 | $0 |
| 2015 | GE | 20,000 | $538,600 | 0 | $0 | 0 | $0 |
| 2012 | GE | 1,000 | $20,580 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cerevel Therapeutics Holdings, Inc. (CERE) by Dekkers Marijn E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | CERE | 0 | $0 | 200,000 | $6,886,000 | 0 | $0 |
| 2021 | CERE | 0 | $0 | 0 | $0 | 14,270 | $0 |
Yearly summary of insider trading at Quanterix Corp (QTRX) by Dekkers Marijn E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | QTRX | 0 | $0 | 61,623 | $3,133,903 | 54,813 | $806,927 |
| 2020 | QTRX | 0 | $0 | 27,619 | $897,341 | 0 | $0 |
| 2019 | QTRX | 0 | $0 | 89,759 | $1,253,035 | 0 | $0 |
Yearly summary of insider trading at Thermo Fisher Scientific Inc. (TMO) by Dekkers Marijn E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | TMO | 0 | $0 | 246,000 | $14,725,160 | 246,000 | $4,000,400 |
| 2007 | TMO | 0 | $0 | 2,055,750 | $108,434,803 | 2,055,750 | $43,417,483 |
| 2006 | TMO | 0 | $0 | 500,000 | $21,905,702 | 500,000 | $9,750,000 |
Yearly summary of insider trading at Ginkgo Bioworks Holdings, Inc. (DNA) by Dekkers Marijn E
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | DNA | 0 | $0 | 1,992,056 | $1,826,112 | 105,263 | $0 |
| 2022 | DNA | 0 | $0 | 171,455 | $438,924 | 0 | $0 |
Insider trading activities at 5 companies by Dekkers Marijn E:
1. General Electric Co (GE)
2. Cerevel Therapeutics Holdings, Inc. (CERE)
3. Quanterix Corp (QTRX)
4. Thermo Fisher Scientific Inc. (TMO)
5. Ginkgo Bioworks Holdings, Inc. (DNA)
Table 1. Insider trading of General Electric Co (GE) by Dekkers Marijn E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-04-24 | GE | Buy | 20,000 | 29.90 | 598,000 |
| 2015-04-22 | GE | Buy | 20,000 | 26.93 | 538,600 |
| 2012-12-27 | GE | Buy | 1,000 | 20.58 | 20,580 |
Table 2. Insider trading of Cerevel Therapeutics Holdings, Inc. (CERE) by Dekkers Marijn E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-06-15 | CERE | Sale | 200,000 | 34.43 | 6,886,000 |
| 2021-09-24 | CERE | Option Ex | 14,270 | .00 | 0 |
Table 3. Insider trading of Quanterix Corp (QTRX) by Dekkers Marijn E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-07 | QTRX | Sale | 9,051 | 55.91 | 506,050 |
| 2021-06-07 | QTRX | Option Ex | 4,732 | 23.12 | 109,403 |
| 2021-06-04 | QTRX | Sale | 7,610 | 55.05 | 418,915 |
| 2021-06-04 | QTRX | Option Ex | 5,119 | 15.64 | 80,061 |
| 2021-01-11 | QTRX | Option Ex | 44,962 | 13.73 | 617,463 |
| 2021-01-11 | QTRX | Sale | 44,962 | 49.13 | 2,208,938 |
| 2020-08-07 | QTRX | Sale | 27,619 | 32.49 | 897,341 |
| 2019-08-20 | QTRX | Sale | 89,759 | 13.96 | 1,253,035 |
Table 4. Insider trading of Thermo Fisher Scientific Inc. (TMO) by Dekkers Marijn E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-08-05 | TMO | Sale | 100,000 | 59.71 | 5,971,000 |
| 2008-08-06 | TMO | Sale | 146,000 | 59.96 | 8,754,160 |
| 2008-08-06 | TMO | Option Ex | 146,000 | 27.40 | 4,000,400 |
| 2006-11-09 | TMO | Option Ex | 100,000 | .00 | 0 |
| 2007-11-27 | TMO | Sale | 10,700 | 57.12 | 611,162 |
| 2007-11-27 | TMO | Option Ex | 132,600 | 19.67 | 2,608,242 |
| 2007-11-27 | TMO | Sale | 121,900 | 56.88 | 6,933,550 |
| 2007-11-26 | TMO | Sale | 129,700 | 56.94 | 7,385,636 |
| 2007-11-26 | TMO | Option Ex | 132,600 | 19.67 | 2,608,242 |
| 2007-11-26 | TMO | Sale | 2,900 | 57.13 | 165,677 |
| 2007-11-06 | TMO | Sale | 2,300 | 57.59 | 132,452 |
| 2007-11-07 | TMO | Sale | 146,000 | 57.06 | 8,331,490 |
| 2007-11-07 | TMO | Option Ex | 146,000 | 27.40 | 4,000,400 |
| 2007-11-06 | TMO | Sale | 143,700 | 57.39 | 8,247,517 |
| 2007-11-06 | TMO | Option Ex | 146,000 | 27.40 | 4,000,400 |
| 2007-09-17 | TMO | Sale | 3,100 | 55.59 | 172,313 |
| 2007-09-17 | TMO | Sale | 89,000 | 55.40 | 4,930,422 |
| 2007-09-17 | TMO | Option Ex | 514,800 | 19.67 | 10,126,116 |
| 2007-09-17 | TMO | Sale | 422,700 | 55.10 | 23,289,924 |
| 2007-09-04 | TMO | Option Ex | 137,090 | 20.27 | 2,778,814 |
| 2007-09-04 | TMO | Sale | 97,190 | 54.27 | 5,274,306 |
| 2007-09-04 | TMO | Sale | 39,900 | 54.69 | 2,182,170 |
| 2007-08-17 | TMO | Sale | 34,878 | 50.70 | 1,768,419 |
| 2007-08-17 | TMO | Option Ex | 150,000 | 21.77 | 3,264,899 |
| 2007-08-17 | TMO | Sale | 115,122 | 50.23 | 5,782,232 |
| 2007-08-15 | TMO | Sale | 24,400 | 52.48 | 1,280,512 |
| 2007-08-15 | TMO | Sale | 75,100 | 52.13 | 3,915,338 |
| 2007-08-15 | TMO | Option Ex | 150,000 | 22.47 | 3,370,500 |
| 2007-08-15 | TMO | Sale | 50,500 | 51.81 | 2,616,304 |
| 2007-01-11 | TMO | Option Ex | 246,660 | 19.50 | 4,809,870 |
| 2007-01-11 | TMO | Sale | 246,660 | 48.02 | 11,843,379 |
| 2007-01-03 | TMO | Option Ex | 300,000 | 19.50 | 5,850,000 |
| 2007-01-03 | TMO | Sale | 300,000 | 45.24 | 13,572,000 |
| 2006-12-01 | TMO | Option Ex | 200,000 | 19.50 | 3,900,000 |
| 2006-12-01 | TMO | Sale | 89,223 | 43.34 | 3,867,370 |
| 2006-12-04 | TMO | Sale | 100,000 | 44.03 | 4,403,500 |
| 2006-12-04 | TMO | Option Ex | 100,000 | 19.50 | 1,950,000 |
| 2006-12-01 | TMO | Sale | 110,777 | 43.60 | 4,829,987 |
| 2006-11-22 | TMO | Option Ex | 60,000 | 19.50 | 1,170,000 |
| 2006-11-22 | TMO | Sale | 60,000 | 44.33 | 2,659,500 |
| 2006-11-20 | TMO | Option Ex | 80,000 | 19.50 | 1,560,000 |
| 2006-11-20 | TMO | Sale | 72,400 | 43.78 | 3,170,033 |
| 2006-11-21 | TMO | Option Ex | 60,000 | 19.50 | 1,170,000 |
| 2006-11-20 | TMO | Sale | 7,600 | 43.52 | 330,752 |
| 2006-11-21 | TMO | Sale | 60,000 | 44.08 | 2,644,560 |
Table 5. Insider trading of Ginkgo Bioworks Holdings, Inc. (DNA) by Dekkers Marijn E
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-12 | DNA | Option Ex | 105,263 | .00 | 0 |
| 2024-05-16 | DNA | Sale | 265,000 | .83 | 219,950 |
| 2024-05-14 | DNA | Sale | 1,727,056 | .93 | 1,606,162 |
| 2022-11-03 | DNA | Sale | 171,455 | 2.56 | 438,924 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Dekkers Marijn E
(Director of Ginkgo Bioworks Holdings, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.